U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class
Concept
Record UNII
73B0K5S26A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BELIMUMAB
DASH   EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
BELIMUMAB [PURPLE BOOK, CDER]
Common Name English
BELIMUMAB [MART.]
Common Name English
GSK-1550188
Code English
HGS1006
Code English
LYMPHOSTAT-B
Brand Name English
BELIMUMAB [MI]
Common Name English
BELIMUMAB (GENETICAL RECOMBINATION) [JAN]
Common Name English
BELIMUMAB [USAN]
Common Name English
HGS-1006
Code English
BEL-114333
Code English
BELIMUMAB [INN]
Common Name English
BELIMUMAB [VANDF]
Common Name English
BELIMUMAB [EMA EPAR]
Common Name English
GSK1550188
Code English
BELIMUMAB [WHO-DD]
Common Name English
BELIMUMAB (GENETICAL RECOMBINATION)
JAN  
Common Name English
IMMUNOGLOBULIN G1, ANTI (HUMAN CYTOKINE BAFF) (HUMAN MONOCLONAL LYMPHOSTAT-B HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LYMPHOSTAT-B .LAMBDA. CHAIN, DIMER
Common Name English
BENLYSTA
Brand Name English
BEL114333
Code English
Classification Tree Code System Code
WHO-ATC L04AA26
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
NDF-RT N0000182637
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
NCI_THESAURUS C20401
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
WHO-VATC QL04AA26
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
EMA ASSESSMENT REPORTS BENLYSTA (AUTHORIZED LUPUS ERYTHEMSTOSUS, SYSTEMIC)
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
Code System Code Type Description
WIKIPEDIA
BELIMUMAB
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY
IUPHAR
6887
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY
NDF-RT
N0000182156
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY Decreased B Lymphocyte Activation [PE]
ChEMBL
CHEMBL1789843
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY
CAS
356547-88-1
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY
RXCUI
1092437
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY RxNorm
NDF-RT
N0000182636
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY B Lymphocyte Stimulator-directed Antibody Interactions [MoA]
EVMPD
SUB25607
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY
LactMed
356547-88-1
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY
MERCK INDEX
M2294
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY Merck Index
INN
8381
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY
NCI_THESAURUS
C91385
Created by admin on Mon Oct 21 23:49:29 UTC 2019 , Edited by admin on Mon Oct 21 23:49:29 UTC 2019
PRIMARY
This is a non-substance concept
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
This is a non-substance concept